4//SEC Filing
Metcalfe David A 4
Accession 0001209191-22-059451
CIK 0000708818other
Filed
Dec 1, 7:00 PM ET
Accepted
Dec 2, 5:05 PM ET
Size
9.3 KB
Accession
0001209191-22-059451
Insider Transaction Report
Form 4
Metcalfe David A
Chief Technology Officer
Transactions
- Exercise/Conversion
Common Stock
2022-12-01$14.07/sh+20,256$285,002→ 193,551 total - Exercise/Conversion
Stock Option (right to buy)
2022-12-01−20,256→ 87,234 totalExercise: $14.07Exp: 2025-10-31→ Common Stock (20,256 underlying) - Sale
Common Stock
2022-12-01$20.58/sh−32,372$666,135→ 161,179 total
Footnotes (3)
- [F1]Pursuant to a 10b5-1(c) plan adopted by the reporting person on March 15, 2022.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.48 to $20.87. Full information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or its stockholders upon request.
- [F3]Original grant of 140,000 options granted on 10/31/2017 vested in four equal, annual installments beginning 10/31/2018.
Documents
Issuer
NEXTGEN HEALTHCARE, INC.
CIK 0000708818
Entity typeother
Related Parties
1- filerCIK 0001664295
Filing Metadata
- Form type
- 4
- Filed
- Dec 1, 7:00 PM ET
- Accepted
- Dec 2, 5:05 PM ET
- Size
- 9.3 KB